SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: (6R,7R)-7-[(R)-2-Amino-2-{4-[(R)-2-amino-2-(4-hydroxyphenyl)acetoxy]phenyl}acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per USP)
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: O=C(C(N12)=C(/C=C\C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(OC([C@H](N)C4=CC=C(O)C=C4)=O)C=C3)=O)C1=O)O
O-D phenylglycine Cefprozil is chemically (6R,7R)-7-[(R)-2-Amino-2-{4-[(R)-2-amino-2-(4-hydroxyphenyl)acetoxy]phenyl}acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per USP). O-D phenylglycine Cefprozil is supplied with detailed characterization data compliant with regulatory guideline. O-D phenylglycine Cefprozil can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefprozil Monohydrate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Stability indicating methods for the analysis of cefprozil in the presence of its alkaline induced degradation product
By Attia, Khalid A. M.; Nassar, Mohammed W. I.; El-Zeiny, Mohamed B.; Serag, Ahmed
From Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy (2016), 159, 1-6
Spectrophotometric determination of cefepime and cefprozil by three different methods
By Abd El-Sattar, Osama I.; El-Abasawy, N. M.; Abd El-Razeq, S. A.; Ismail, M. M. F.; Rashed, N. S.
From Saudi Pharmaceutical Journal (2001), 9(3-4), 186-191
